My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1387

    1.

    Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes.

    Goldberg IJ, Hu Y, Noh HL, Wei J, Huggins LA, Rackmill MG, Hamai H, Reid BN, Blaner WS, Huang LS.

    Diabetes. 2008 Jun;57(6):1674-82. Epub 2008 Mar 17.PMID: 18346984 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice.

    Ebara T, Conde K, Kako Y, Liu Y, Xu Y, Ramakrishnan R, Goldberg IJ, Shachter NS.

    J Clin Invest. 2000 Jun;105(12):1807-18.PMID: 10862796 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Overexpression of apolipoprotein E prevents development of diabetic hyperlipidemia in transgenic mice.

    Yamamoto K, Shimano H, Shimada M, Kawamura M, Gotoda T, Harada K, Ohsuga J, Yazaki Y, Yamada N.

    Diabetes. 1995 May;44(5):580-5.PMID: 7729619 [PubMed - indexed for MEDLINE]Related articles

    4.

    Regulation of the apolipoprotein E by dietary lipids occurs by transcriptional and post-transcriptional mechanisms.

    Srivastava RA.

    Mol Cell Biochem. 1996 Feb 23;155(2):153-62.PMID: 8700160 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of streptozotocin-induced diabetes in apolipoprotein AI deficient mice.

    Goldberg IJ, Isaacs A, Sehayek E, Breslow JL, Huang LS.

    Atherosclerosis. 2004 Jan;172(1):47-53.PMID: 14709356 [PubMed - indexed for MEDLINE]Related articles

    6.

    Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis.

    Post SM, de Roos B, Vermeulen M, Afman L, Jong MC, Dahlmans VE, Havekes LM, Stellaard F, Katan MB, Princen HM.

    Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1551-6.PMID: 10845871 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice.

    Vasandani C, Kafrouni AI, Caronna A, Bashmakov Y, Gotthardt M, Horton JD, Spady DK.

    J Lipid Res. 2002 May;43(5):772-84.PMID: 11971949 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice. Effects on lipoproteins and atherosclerosis.

    Kako Y, Huang LS, Yang J, Katopodis T, Ramakrishnan R, Goldberg IJ.

    J Lipid Res. 1999 Dec;40(12):2185-94.PMID: 10588944 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.

    Véniant MM, Zlot CH, Walzem RL, Pierotti V, Driscoll R, Dichek D, Herz J, Young SG.

    J Clin Invest. 1998 Oct 15;102(8):1559-68.PMID: 9788969 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Lipoprotein subclass profiles of hyperlipidemic diabetic mice measured by nuclear magnetic resonance spectroscopy.

    Hammad SM, Powell-Braxton L, Otvos JD, Eldridge L, Won W, Lyons TJ.

    Metabolism. 2003 Jul;52(7):916-21.PMID: 12870170 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.

    Shi W, Wang X, Wong J, Hedrick CC, Wong H, Castellani LW, Lusis AJ.

    Biochem Biophys Res Commun. 2004 Apr 23;317(1):223-9.PMID: 15047172 [PubMed - indexed for MEDLINE]Related articles

    12.

    Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL.

    Horton JD, Shimano H, Hamilton RL, Brown MS, Goldstein JL.

    J Clin Invest. 1999 Apr;103(7):1067-76.PMID: 10194480 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.

    Shimano H, Yamada N, Katsuki M, Yamamoto K, Gotoda T, Harada K, Shimada M, Yazaki Y.

    J Clin Invest. 1992 Nov;90(5):2084-91.PMID: 1430232 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Dietary cholate increases plasma levels of apolipoprotein B in mice by posttranscriptional mechanisms.

    Srivastava RA, Averna M, Srivastava N, Pape ME.

    Int J Biochem Cell Biol. 2001 Dec;33(12):1215-26.PMID: 11606258 [PubMed - indexed for MEDLINE]Related articles

    15.

    Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.

    Nakamuta M, Chang BH, Zsigmond E, Kobayashi K, Lei H, Ishida BY, Oka K, Li E, Chan L.

    J Biol Chem. 1996 Oct 18;271(42):25981-8.PMID: 8824235 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Apolipoprotein E-containing lipoproteins and lipoprotein remnants in experimental canine diabetes.

    Wilson DE, Chan IF, Elstad NL, Peric-Golia L, Hejazi J, Albu DS, Cutfield R.

    Diabetes. 1986 Aug;35(8):933-42.PMID: 3732634 [PubMed - indexed for MEDLINE]Related articles

    17.

    Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol.

    Zabalawi M, Bhat S, Loughlin T, Thomas MJ, Alexander E, Cline M, Bullock B, Willingham M, Sorci-Thomas MG.

    Am J Pathol. 2003 Sep;163(3):1201-13.PMID: 12937162 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins.

    Ishibashi S, Herz J, Maeda N, Goldstein JL, Brown MS.

    Proc Natl Acad Sci U S A. 1994 May 10;91(10):4431-5.PMID: 8183926 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.

    Huang Y, Liu XQ, Rall SC Jr, Mahley RW.

    J Biol Chem. 1998 Jul 10;273(28):17483-90.PMID: 9651338 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Normal production rate of apolipoprotein B in LDL receptor-deficient mice.

    Millar JS, Maugeais C, Fuki IV, Rader DJ.

    Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):989-94.PMID: 12067909 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity